6.44MMarket Cap
LossP/E TTM
Kairos Pharma Ltd's Company Valuation
Currency: USD Updated: 2026-07-31The current valuation score of Kairos Pharma Ltd is 5.41, ranking 364 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -1.04, which is -6.90% below the recent high of -0.97 and -1503.13% above the recent low of -16.65.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.